dc.creator | Greco, Giulia | es |
dc.creator | Pellicioni, Valentina | es |
dc.creator | Cruz Chamorro, Iván | es |
dc.creator | Attisani, Giuseppe | es |
dc.creator | Stefanelli, Claudio | es |
dc.creator | Fimognari, Carmela | es |
dc.date.accessioned | 2023-05-10T13:29:57Z | |
dc.date.available | 2023-05-10T13:29:57Z | |
dc.date.issued | 2022-10-27 | |
dc.identifier.citation | Greco, G., Pellicioni, V., Cruz Chamorro, I., Attisani, G., Stefanelli, C. y Fimognari, C. (2022). Marine-Derived Compounds Targeting Topoisomerase II in Cancer Cells A Review. Marine Drugs, 20 (11), 674. https://doi.org/10.3390/md20110674. | |
dc.identifier.issn | 1660-3397 | es |
dc.identifier.uri | https://hdl.handle.net/11441/145801 | |
dc.description.abstract | Cancer affects more than 19 million people and is the second leading cause of death in the world. One of the principal strategies used in cancer therapy is the inhibition of topoisomerase II, involved in the survival of cells. Side effects and adverse reactions limit the use of topoisomerase II inhibitors; hence, research is focused on discovering novel compounds that can inhibit topoisomerase II and have a safer toxicological profile. Marine organisms are a source of secondary metabolites with different pharmacological properties including anticancer activity. The objective of this review is to present and discuss the pharmacological potential of marine-derived compounds whose antitumor activity is mediated by topoisomerase II inhibition. Several compounds derived from sponges, fungi, bacteria, ascidians, and other marine sources have been demonstrated to inhibit topoisomerase II. However, some studies only report docking interactions, whereas others do not fully explain the mechanisms of topoisomerase II inhibition. Further in vitro and in vivo studies are needed, as well as a careful toxicological profile evaluation with a focus on cancer cell selectivity. | es |
dc.format | application/pdf | es |
dc.format.extent | 56 p. | es |
dc.language.iso | eng | es |
dc.publisher | MDPI | es |
dc.relation.ispartof | Marine Drugs, 20 (11), 674. | |
dc.rights | Atribución 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | topoisomerase II | es |
dc.subject | cancer chemotherapy | es |
dc.subject | marine compounds | es |
dc.subject | sponges | es |
dc.subject | marine fungi | es |
dc.subject | marine bacteria | es |
dc.subject | marine invertebrates | es |
dc.title | Marine-Derived Compounds Targeting Topoisomerase II in Cancer Cells A Review | es |
dc.type | info:eu-repo/semantics/article | es |
dcterms.identifier | https://ror.org/03yxnpp24 | |
dc.type.version | info:eu-repo/semantics/publishedVersion | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.contributor.affiliation | Universidad de Sevilla. Departamento de Bioquímica Médica y Biología Molecular e Inmunología | es |
dc.relation.projectID | VIIPPIT-2022-III.2 | es |
dc.relation.projectID | DOC_00587/2020 | es |
dc.relation.publisherversion | https://www.mdpi.com/1660-3397/20/11/674 | es |
dc.identifier.doi | 10.3390/md20110674 | es |
dc.journaltitle | Marine Drugs | es |
dc.publication.volumen | 20 | es |
dc.publication.issue | 11 | es |
dc.publication.initialPage | 674 | es |
dc.contributor.funder | VII Programa de Iniciativa Interna para la Investigación y la Transferencia de la Universidad de Sevilla | es |
dc.contributor.funder | Consejería de Economía, Conocimiento, Empresa y Universidad de la Junta de Andalucía | es |